The tenth fund is significantly bigger than its predecessor, which topped out at $419 million in 2017. However, Dan Estes, general partner at Frazier, expects the additional funding to have little effect on the investment approach.https://www.fiercebiotech.com/biotech/frazier-closes-617m-life-science-fund-creating-scope-for-bigger-bets …
0 replies
1 proslijeđeni tweet
7 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.